Risk stratification and therapeutic decision making in acute coronary syndromes

JAMA

Volumn 284, Issue 7, 2000, Pages 876-878

  Magnus Ohman, E ^a   Granger, C B ^a   Harrington, R A ^a   Lee, K L ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DALTEPARIN; ENOXAPARIN; EPTIFIBATIDE; FIBRINOLYTIC AGENT; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; TROPONIN;

ACUTE HEART INFARCTION; AGE; CLINICAL TRIAL; COMPUTER SYSTEM; HEART FAILURE; HEART LEFT BUNDLE BRANCH BLOCK; HUMAN; MEDICAL DECISION MAKING; MORTALITY; NOTE; PRIORITY JOURNAL; RISK ASSESSMENT; ST SEGMENT ELEVATION; UNSTABLE ANGINA PECTORIS;

EID: 0034675048     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.284.7.876     Document Type: Note

References (25)

1. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2
2. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
3. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction
4. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction: Results from an international trial of 41,021 patients
5. Selection of thrombolytic therapy for individual patients: Development of a clinical model
6. Prediction of 1-year survival after thrombolysis for acute myocardial infarction in the Global Utilization of Streptokinase and tPA for Occluded Coronary Arteries trial
7. Exercise treadmill score for predicting prognosis in coronary artery disease
8. Evaluating the yield of medical tests
9. Diagnosing and managing unstable angina
10. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation: Results from an international trial of 9461 patients
11. Prognostic value of the admission electrocardiogram in acute coronary syndromes
12. Predictors of recurrent ischemic events and death in unstable coronary artery disease after treatment with combination antithrombotic therapy
13. The TJMJ risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making
14. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease
15. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction: Results of the Thrombolysis in Myocardial Infarction (TIMI) 11B trial
16. Treatment of myocardial infarction in a coronary care unit: A two-year experience with 250 patients
17. Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: A meta-analysis
18. Low-molecular-weight heparin in acute coronary syndrome: Evidence for superior or equivalent efficacy compared with unfractionated heparin?
19. Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction: TIMI 11B-ESSENCE meta-analysis
20. Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection
21. Clinical outcomes of therapeutic agents that block the platelet glycoprotein llb/Illa integrin in ischemic heart disease
22. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels
23. Angiographic findings in patients with refractory unstable angina according to troponin T status
24. Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban